{
  "id": 500115,
  "title": "MBNL1 identified as a potential cancer drug target for a type of childhood leukemia",
  "url": "https://urgent.news/2026/08/10/mbnl1-identified-as-a-potential-cancer-drug-target-for-a-type-of",
  "topic": "science",
  "section": "Science",
  "published": "2026-08-10T19:20:02.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-mbnl1-potential-cancer-drug-childhood.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Scientists from St. Jude Children's Research Hospital and collaborators have discovered that the RNA-binding protein MBNL1 promotes the growth of a form of childhood leukemia characterized by KMT2A gene rearrangements. The finding identifies MBNL1 as a promising therapeutic target for future drug development. The results were published August 7 in Science Advances.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}